These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30487328)

  • 21. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Secondary osteoporosis or secondary contributors to bone loss in fracture. causes and pathophysiology of secondary osteoporosis].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2013 Sep; 23(9):1251-7. PubMed ID: 23999359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary causes of osteoporosis.
    Hudec SM; Camacho PM
    Endocr Pract; 2013; 19(1):120-8. PubMed ID: 23186949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone loss is more severe in younger Cushing's syndrome women than in older ones: comparison of bone mineral density between Cushing's syndrome and healthy women].
    Jiang Y; Meng XW; Lu ZL; Xia WB; Xing XP; Li M; Wang O; Yu W; Tian JP
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1695-7. PubMed ID: 17825152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Drug-induced osteoporosis: glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2015 Sep; 25(9):1347-56. PubMed ID: 26320535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
    Takayanagi R
    Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome.
    Belaya ZE; Hans D; Rozhinskaya LY; Dragunova NV; Sasonova NI; Solodovnikov AG; Tsoriev TT; Dzeranova LK; Melnichenko GA; Dedov II
    Arch Osteoporos; 2015; 10():44. PubMed ID: 26608406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal incidentalomas and subclinical Cushing's syndrome: is there evidence for glucocorticoid-induced osteoporosis?
    Angeli A; Osella G; Reimondo G; Terzolo M
    Front Horm Res; 2002; 30():73-85. PubMed ID: 11892272
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.
    Kenanidis E; Potoupnis ME; Kakoulidis P; Leonidou A; Sakellariou GT; Sayegh FE; Tsiridis E
    Expert Opin Drug Saf; 2015 Jul; 14(7):1035-53. PubMed ID: 25952267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy.
    Hardy RS; Zhou H; Seibel MJ; Cooper MS
    Endocr Rev; 2018 Oct; 39(5):519-548. PubMed ID: 29905835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six controversial issues on subclinical Cushing's syndrome.
    Chiodini I; Albani A; Ambrogio AG; Campo M; De Martino MC; Marcelli G; Morelli V; Zampetti B; Colao A; Pivonello R;
    Endocrine; 2017 May; 56(2):262-266. PubMed ID: 27406391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cushing's syndrome, glucocorticoids and the kidney.
    Smets P; Meyer E; Maddens B; Daminet S
    Gen Comp Endocrinol; 2010 Oct; 169(1):1-10. PubMed ID: 20655918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T
    Clin Calcium; 2015 Dec; 25(12):1825-34. PubMed ID: 26608858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cushing's syndrome and bone.
    Mancini T; Doga M; Mazziotti G; Giustina A
    Pituitary; 2004; 7(4):249-52. PubMed ID: 16010458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cushing's syndrome, osteoporosis and multiple fractures.
    LEWIS AA
    Proc R Soc Med; 1950 Nov; 43(11):908-9. PubMed ID: 14797709
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glucocorticoid and Bone. Fracture risk of steroid-induced osteoporosis].
    Fujiwara S
    Clin Calcium; 2014 Sep; 24(9):1295-300. PubMed ID: 25177001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporotic fractures at presentation of Cushing's disease: two case reports and a literature review.
    Khanine V; Fournier JJ; Requeda E; Luton JP; Simon F; Crouzet J
    Joint Bone Spine; 2000; 67(4):341-5. PubMed ID: 10963086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glucocorticoid and Bone. Updated Japanese guidelines for the management of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Sep; 24(9):1309-18. PubMed ID: 25177003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.